Chemung Canal Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Chemung Canal Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,732	Closed	-$428K	–	114
2019 Q1	$428K	Buy	+4,732	New	+$403K	0.1%	90
2018 Q4	–	Sell	-66,872	Closed	-$6.41M	–	112
2018 Q3	$6.41M	Sell	66,872 -22,479	-25%	-$2.18M	1.42%	28
2018 Q2	$8.51M	Sell	89,351 -9,740	-10%	-$895K	2.05%	17
2018 Q1	$8.69M	Buy	99,091 +12,249	+14%	+$1.12M	2.08%	16
2017 Q4	$7.37M	Buy	86,842 +24,798	+40%	+$2.08M	1.61%	27
2017 Q3	$5.37M	Buy	62,044 +9,516	+18%	+$763K	1.22%	34
2017 Q2	$4.05M	Buy	+52,528	New	+$3.73M	0.94%	40

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Chemung Canal Trust's XBI Position: Q2 2019 in Review

Chemung Canal Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 4,732 shares — an estimated $428K sold.

Chemung Canal Trust first reported a position in XBI in Q2 2017 and held it in 7 quarters. The position peaked at $8.69M in Q1 2018. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

Chemung Canal Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
Chemung Canal Trust sold 4,732 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $428K.
Chemung Canal Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 7 quarters.
Chemung Canal Trust's State Street SPDR S&P Biotech ETF position peaked at $8.69M in Q1 2018.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Chemung Canal Trust's 13F filing for Q2 2019, filed 22 Jul 2019.